N+1 Singer

N+1 Singer was a leading UK-based investment bank and corporate broker that specialized in the small and mid-cap equity markets. The firm was particularly well-known for its expertise in the healthcare and life sciences sectors, providing corporate finance advisory, equity research, and sales and trading services to numerous AIM-listed companies. Formed in 2012 through the merger of N+1 Brewin and Singer Capital Markets, it established itself as a top-tier Nominated Adviser (NOMAD) for growth companies in the United Kingdom. In 2021, N+1 Singer merged with FinnCap Group to create a larger mid-market financial services powerhouse. Following a subsequent merger between FinnCap and Cenkos Securities in 2023, the combined entity now operates under the brand name Cavendish.